Clot prevention is a common clinical dilemma – what to do when, and how to balance risks and benefits.
Warfarin is commonly used in a number of clinical settings.
Given the difficulties in managing patients taking warfarin,
several questions are usually raised by clinicians in relation
to its use.
This article addresses some of the clinical questions related
to warfarin use.
Routine genetic testing before warfarin initiation is
not currently recommended. None of the new oral
anticoagulants is marketed in Australia for long term
therapy as warfarin substitutes. Strategies to prevent
thrombosis associated with air travel are discussed and
measures to minimise the risk of bleeding are highlighted.
Download the PDF for the full article.